Xilinx Updates March Quarter Guidance
SAN JOSE, Calif., March 5, 2007 -- Xilinx, Inc. (Nasdaq: XLNX) today released its business update for the March quarter of fiscal 2007.
- March quarter sales guidance range has been narrowed to flat to down 4% sequentially. This is a change from flat to down 5% sequentially.
- Gross margin guidance is unchanged and expected to be approximately 61%, including $2 million of stock-based compensation.
- As a result of the convertible debt offering and concurrent share buyback, Xilinx expects the share count reduction to have a minimal impact to fourth quarter 2007 results. Other Income will be approximately $19 million. For fiscal year 2008, the Company expects a fully diluted share count of approximately 300 million based on the current stock price. Other Income will decline by approximately $31-32 million per year. All the repurchases of common stock are conditioned upon the closing of the offering of the debentures.
No conference call will be held in conjunction with this guidance revision. Additional commentary pertaining to the quarter will be available when the company reports its fourth quarter financial results on April 25, 2007.
About Xilinx
Xilinx, Inc. (Nasdaq: XLNX) is the worldwide leader of programmable logic solutions. Additional information about Xilinx is available at http://www.xilinx.com.
|
Xilinx, Inc. Hot IP
Related News
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |